Metyrosine 250 MG Oral Capsule — RxCUI 197980
RxNorm drug concept · Semantic clinical drug
RxCUI 197980
Semantic clinical drug · SCD
● Current RxNorm concept 4 FDA products
6 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI197980
Official nameMetyrosine 250 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped4
Package NDCs mapped6
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
🕸️ Concept Web — How Metyrosine 250 MG Oral Capsule Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Metyrosine 250 MG Oral Capsule
RxCUI 197980 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Metyrosine
266604IN
-
Metyrosine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Demser
151594BN
-
Demser
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Metyrosine Oral Capsule
541038SCDF -
Metyrosine Oral Product
1164090SCDG -
Metyrosine Pill
1164091SCDG -
Metyrosine Oral Capsule [Demser]
366207SBDF -
Demser Oral Product
1172436SBDG -
Demser Pill
1172437SBDG -
Oral Capsule
316965DF -
Oral Product
1151131DFG - +1 more in this family
-
Metyrosine Oral Capsule
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Metyrosine 250 MG
541037SCDC -
Metyrosine 250 MG Oral Capsule [Demser]
201388SBD -
Metyrosine 250 MG [Demser]
541040SBDC
-
Metyrosine 250 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Metyrosine 250 MG
SCDC · 541037 -
Metyrosine Oral Capsule
SCDF · 541038 -
Metyrosine Oral Product
SCDG · 1164090 -
Metyrosine Pill
SCDG · 1164091
Brand-Name Concepts
-
Metyrosine 250 MG Oral Capsule [Demser]
SBD · 201388 -
Metyrosine 250 MG [Demser]
SBDC · 541040 -
Metyrosine Oral Capsule [Demser]
SBDF · 366207 -
Demser Oral Product
SBDG · 1172436 -
Demser Pill
SBDG · 1172437 -
Demser
BN · 151594
📦 FDA Products & Package NDCs
4 products · 6 package NDCs
6 package NDCs map to RxCUI 197980 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 25010-0305-15 | 100 CAPSULE in 1 BOTTLE (25010-305-15) | Demser | Bausch Health US, LLC | 1979-10-03 |
| 68682-0310-01 | 100 CAPSULE in 1 BOTTLE (68682-310-01) | Metyrosine | Oceanside Pharmaceuticals | 2020-09-07 |
| 69238-1621-01 | 100 CAPSULE in 1 BOTTLE, PLASTIC (69238-1621-1) | metyrosine | Amneal Pharmaceuticals NY LLC | 2020-07-24 |
| 69238-1621-03 | 30 CAPSULE in 1 BOTTLE, PLASTIC (69238-1621-3) | metyrosine | Amneal Pharmaceuticals NY LLC | 2020-12-15 |
| 75907-0166-01 | 100 CAPSULE in 1 BOTTLE (75907-166-01) | METYROSINE | Dr. Reddy's Laboratories Inc. | 2025-05-30 |
| 75907-0166-30 | 30 CAPSULE in 1 BOTTLE (75907-166-30) | METYROSINE | Dr. Reddy's Laboratories Inc. | 2025-05-30 |
Observed labelers:
Amneal Pharmaceuticals NY LLC (2) ·
Dr. Reddy's Laboratories Inc. (2) ·
Bausch Health US, LLC (1) ·
Oceanside Pharmaceuticals (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.